Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Aggression Therapy
Research from MetroHealth Medical Center provides new data about aggression therapy
March 16th, 2008
A new study, 'Atypical antipsychotic medication improves aggression, but not self-injurious behaviour, in adults with intellectual disabilities,' is now available. According to recent research from the United States, "Atypical antipsychotic medications have largely supplanted their typical counterparts, both for psychosis and for the treatment of aggression and/or self-injurious behaviour (SIB), in persons with intellectual disabilities (ID). However, with the exception of risperidone, little systematic research supports their use in such persons." "A retrospective review of 31 adult residents of a state developmental centre, who were treated for aggression and/or SIB...
Source: Pharma Investments, Ventures & Law Weekly (2008-03-16)
|
